Counterpoint Mutual Funds LLC bought a new stake in Maximus, Inc. (NYSE:MMS – Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 65,452 shares of the health services provider’s stock, valued at approximately $4,195,000.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Farther Finance Advisors LLC boosted its position in shares of Maximus by 69.0% during the 4th quarter. Farther Finance Advisors LLC now owns 284 shares of the health services provider’s stock worth $25,000 after acquiring an additional 116 shares in the last quarter. Advisory Services Network LLC bought a new position in Maximus in the third quarter valued at approximately $32,000. Northwestern Mutual Wealth Management Co. raised its position in Maximus by 225.2% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 439 shares of the health services provider’s stock valued at $38,000 after purchasing an additional 304 shares in the last quarter. Richardson Financial Services Inc. raised its position in Maximus by 29.6% during the fourth quarter. Richardson Financial Services Inc. now owns 451 shares of the health services provider’s stock valued at $39,000 after purchasing an additional 103 shares in the last quarter. Finally, Canada Pension Plan Investment Board bought a new stake in Maximus during the second quarter worth $35,000. Institutional investors own 97.21% of the company’s stock.
Maximus Trading Up 0.1%
Shares of Maximus stock opened at $55.80 on Friday. The firm has a market capitalization of $2.93 billion, a PE ratio of 8.35 and a beta of 0.60. The company has a current ratio of 2.21, a quick ratio of 2.21 and a debt-to-equity ratio of 0.87. The firm’s 50 day moving average is $60.38 and its 200 day moving average is $72.90. Maximus, Inc. has a 1 year low of $52.73 and a 1 year high of $100.00.
Maximus Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Monday, June 1st. Investors of record on Friday, May 15th were given a dividend of $0.33 per share. The ex-dividend date was Friday, May 15th. This represents a $1.32 dividend on an annualized basis and a yield of 2.4%. Maximus’s payout ratio is currently 19.76%.
Wall Street Analysts Forecast Growth
A number of equities research analysts have weighed in on MMS shares. Wall Street Zen raised Maximus from a “hold” rating to a “buy” rating in a report on Saturday, June 6th. Zacks Research cut Maximus from a “strong-buy” rating to a “hold” rating in a report on Monday, April 27th. Finally, Weiss Ratings downgraded Maximus from a “hold (c)” rating to a “hold (c-)” rating in a research report on Wednesday, May 20th. Two research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the company has an average rating of “Hold”.
View Our Latest Research Report on MMS
About Maximus
Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.
Read More
- Five stocks we like better than Maximus
- AST SpaceMobile’s Japan Catalyst Puts Its Rollout Story Back in Focus
- Gold and Silver Recovery—3 Precious Metals Stocks for H2 2026
- Klarna’s Google Court Win Could Give Its BNPL Story a Needed Cash Catalyst
- Why Kroger’s Giant Eagle Deal Could Change Everything
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS – Free Report).
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.
